AUTL AUTOLUS THERAPEUTICS PLC

Ownership history in Blackstone Inc.  ·  17 quarters on record

This page tracks every 13F SEC filing in which Blackstone Inc. reported a position in AUTOLUS THERAPEUTICS PLC (AUTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.59% (2023 Q4)
Avg. % of fund
0.24%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 20,485,611 0% 0.16% $40.8M $1.99
2025 Q3 UNCHANGED 20,485,611 0% 0.13% $33.4M $1.63
2025 Q2 UNCHANGED 20,485,611 0% 0.20% $46.7M $2.28
2025 Q1 UNCHANGED 20,485,611 0% 0.13% $31.8M $1.55
2024 Q4 UNCHANGED 20,485,611 0% 0.22% $48.1M $2.35
2024 Q3 UNCHANGED 20,485,611 0% 0.32% $74.4M $3.63
2024 Q2 UNCHANGED 20,485,611 0% 0.30% $71.3M $3.48
2024 Q1 UNCHANGED 20,485,611 0% 0.53% $130.7M $6.38
2023 Q4 UNCHANGED 20,485,611 0% 0.59% $131.9M $6.44
2023 Q3 UNCHANGED 20,485,611 0% 0.20% $47.7M $2.33
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AUTL price (monthly, adj. close)
← Back to Blackstone Inc. Holdings